Love et al. [25] further concluded that the expression of CD200 in MCC merits further studies to determine whether CD200 plays a role in the biology of the disease, if CD200 represents a potential therapeutic target, or if loss of CD200 affects prognosis. This evidence concerns the gene CD200 and Merkel cell skin cancer.